Dr. Sheinkop had over 37 years of experience in joint replacement surgery before moving into the field of regenerative medicine, according to a Feb. 16 press release.
QC Kinetix utilizes regenerative medicine treatments to allow the body to treat itself, so patients can avoid surgery for musculoskeletal discomfort.
In his position, Dr. Sheinkop will head the medical management team, focusing on the evaluation and enhancement of protocols, as well as spearheading research and development initiatives. Additionally, he will focus on refining the training and certification processes for practitioners.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
